Publication Name	World Journal of Gastroenterology
Manuscript ID	4370
Country	Portugal

Received	2013-06-28 11:36
Peer-Review Started	2013-06-28 17:45
To Make the First Decision	2013-07-05 18:34
Return for Revision	2013-07-08 14:40
Revised	2013-07-28 16:19
Second Decision	2013-08-19 12:24
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-08-20 00:05
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2013-10-21 17:43
Publish the Manuscript Online	2013-11-13 08:37

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Hepatitis C, stigma and cure
Manuscript Source	Invited Manuscript
All Author List	Rui Tato Marinho and David Pires Barreira
Funding Agency and Grant Number
Corresponding Author	Rui Tato Marinho, MD, PhD, Department of Gastroenterology and Hepatology, Hospital Santa Maria, Medical School of Lisbon, Av. Prof. Egas Moniz, 1649-035 Lisboa, Portugal. rui.marinho@mail.telepac.pt
Key Words	Hepatitis C; Chronic; Therapy; Hepatocellular carcinoma; Hepatic cirrhosis; Interferon-alpha; Ribavirin; Social stigma; Depression
Core Tip	Around 3% of the world population, about 170-200 million people are infected with hepatitis C virus. The chronic consequences of the infection are liver cirrhosis and hepatocellular carcinoma, which appears in 20%-40% of the patients. Hepatitis C is not only a liver disease but also a mental, psychological, familiar, and social disease. The stigma that the infected person sometimes carries is tremendous. But, besides the "drama" of being infected, health professionals, family, society and infected patients, must be aware of the chance of real cure and definitive elimination of the virus. Step by step, the efficacy of the therapy for hepatitis C is rapidly increasing and with the new medications, the Direct Antiviral Agents-DAAs, is around 80%-90%.
Publish Date	2013-11-13 08:37
Citation	Marinho RT, Barreira DP. Hepatitis C, stigma and cure. World J Gastroenterol 2013; 19(40): 6703-6709
URL	http://www.wjgnet.com/1007-9327/full/v19/i40/6703.htm
DOI	http://dx.doi.org/10.3748/wjg.v19.i40.6703

Full Article (PDF)	WJG-19-6703.pdf
Manuscript File	4370-Review.docx
Answering Reviewers	4370-Answering reviewers.pdf
Copyright License Agreement	4370-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	4370-Language certificate.pdf
Peer-review Report	4370-Peer review(s).pdf
Scientific Editor Work List	4370-Scientific editor work list.doc